Johnson & Johnson ( JNJ) - Stock Earnings
JNJ Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2026Q1 | 5.2 billion USD | 24.1 billion USD |
| 2026Q2 | 5.5 billion USD | 25.3 billion USD |
| 2026Q3 | 210.0 million USD | 25.4 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
JNJ Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 35.2 billion USD | 85.2 billion USD |
| 2024 | 14.1 billion USD | 88.8 billion USD |
| 2025 | 26.8 billion USD | 94.2 billion USD |
| 2026 Est. | — | — |
JNJ
List: Champions
Price: $271.22
Dividend Yield: 0.51%
Forward Dividend Yield: 1.98%
Payout Ratio: 75.04%
Dividend Per Share: 5.36 USD
Earnings Per Share: 6.59 USD
P/E Ratio: 38.78
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 6.9 million
Ebitda: 2.9 billionMarket Capitalization: 615.9 billion
Average Dividend Frequency: 4
Years Paying Dividends: 26
DGR3: 4.92%
DGR5: 5.25%
DGR10: 5.71%
DGR20: 7.24%